Drugs of Abuse Testing Market: Manufacturers Focused on Developing Newer Testing Techniques for Better and Quick Results: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
- REP-GB-1649
- 2018-01-22
- Category: Healthcare, Pharmaceuticals and Medical devices
- 254 Pages
- Format:
Rapid testing technique market is anticipated to grow at the fastest rate during 2017-2027
Drugs of abuse testing involves detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. The process is carried out with the help of various techniques like Immunoassays Analyzers, Chromatography and Rapid Testing. Immunoassays Analyzers is the equipment that helps in biochemical tests that helps detect or quantify specific proteins or drug substances. The process takes place with the help of antigens or antibodies that perform the test. This segment contains that work on the principle of immunoassay technique like the electronic equipment or simple point of care tests that contain antibodies and bind to the antigen. Chromatographic devices divide the technique into component parts for detecting specific drugs or components with the help of devices like Gas Chromatography, Liquid Chromatography (LC), Gas Chromatography etc. Rapid testing includes consumables like clude test kits, reagents and fluids for conducting tests to detect the drugs of the sample. Among these technique types of the drugs of abuse testing market, our forecasts indicate that the rapid testing segment is expected to grow at the highest rate with a 6.6% CAGR during the forecast period. However immunoassay is predicted to hold the maximum market size of over US$ 870 Mn by the end of the study period.
The case of prescribed drugs abuse is expected to rise exponentially, resulting in a growing need for awareness creation among people
The trend of drugs abuse is largely witnessed in the case of prescribed drugs. Growth in prescription drugs abuse is skyrocketing and in turn is increasing the rate of emergency room visits and deaths by overdose. This is because of the nonmedical consumption of prescription drugs that is growing very rapidly. According to the 2010 National Survey on Drug Use and Health (NSDUH), an estimated 2.4 million people in the U.S. use prescription drugs for nonmedical purposes. As a result, manufacturers of drug abuse testing are focussing on creating awareness among people and drug store owners regarding the effects of drug abuse and importance of drug screening. Companies are also providing training on the identification of potential drug and alcohol abusers as well as on the use of drug abuse tests to law enforcement agencies.
Governments as well as companies to focus more on the implementation of prevention strategies for drug abuse
Drug abuse is currently creating a very huge impact on the global population. People with prolonged drug or alcohol abuse start suffering from chronic diseases like diabetes and heart disease. Such diseases prevailing among the people also impacts the economy and turns out to be a burden on the government. This has in turn made governments across the world to focus more on prevention and early intervention strategies for drug abuse. This has exceptionally driven the global drugs of abuse testing market. Owing to reduced productivity of individuals using illicit drugs, several employers are also emphasizing on protecting their workforce from drug abuse by conducting regular drugs of abuse tests as individuals using illicit drugs are more likely to change jobs, be less productive, be absent frequently and are more likely to get involved in workplace accidents. Owing to these factors, the demand for drugs of abuse testing from both private and public sector companies is expected to grow rapidly over the forecast period.
Our new research report focusses on the global drugs of abuse testing market by briefing the scenario of the market during the forecast period 2017-2027. The report covers all the major aspects of the market including market growth rate, market size, trends governing the market, drivers fuelling the market growth, restraints limiting the market and also the pricing analysis of the market. This comprehensive research report has been prepared with the help of our team of expert analysts who have followed a vigorous research process in order to get the final results of the market analysis. The research programme considers the various macro-economic factors that have impacted the market growth including the demand for different types of drugs or drug testing methods. To simplify the process of research the market has been divided into various segments based on region, drug class, technique type and end user. This helps the readers understand the individual analysis of every segment in the market and also the most lucrative and well performing segments to invest in. The segmentation also helps businesses looking for opportunities in the global market to avoid any kind of losses at crucial times.
Segmentation of the drugs of abuse testing market
|
Drug Type |
Technique Type |
End User |
Region |
|---|---|---|---|
|
|
|
|
Report Structure
The report has been given a systematic structure to maintain a consistent flow. The report starts with the executive summary and basic definition of the market. The executive summary includes an overview of the major research outcomes, which also gives readers an idea about what is being projected in the report. The basic definition gives the meaning of the market and the products of the drug abuse testing market. It helps understanding the market easier for every person.
This is followed by market segmentation and an individual analysis of every segment the market is bifurcated in. Another important section of the report is the competitive landscape of the market. It depicts a complete scenario of companies operating in the drugs of abuse testing market along with a SWOT analysis of the profiled companies. The competitive landscape helps the new entrants as well as the existing players of the market to know the strategies of the key players in the market. It makes the companies or the businesses capable of competing efficiently.
Reasons to invest in this research report
The report is intended to cater to the people from every sector and educate them with useful insights on the global drugs of abuse testing market. The study involves a systematic research methodology comprising in-depth primary and secondary research. It consists of important information curated from different reliable sources like interviews of industry experts. It also includes information from company websites, annual reports, white papers, financial reports etc. This data is then validated using the triangulation method, wherein secondary, primary and FMI analysis contribute to the final data. The report works as a guide to the market and presents the most useful information in a manner that is easily understandable.
Drug Of Abuse Testing Market Reports - Table of Contents
1. Executive Summary
1.1. Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
1.5. Report Inclusions and Exclusions
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Drugs of Abuse Testing Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Drivers
3.4. Restraints
3.5. Opportunities
3.6. Trends
3.7. Porter’s Analysis
3.8. Key Industry Developments
3.9. Key Regulatory
3.10.Technology Assessment
4. North America Drugs of Abuse Testing Market Analysis 2012–2016 and Forecast 2017–2027
4.1. Introduction
4.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
4.2.1. U.S.
4.2.2. Canada
4.3. Market Size (US$ Mn) Forecast By Country, 2017–2027
4.3.1.U.S.
4.3.2.Canada
4.4. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
4.4.1.Psychostimulants
4.4.2. Narcotic
4.4.3. Hallucinogens
4.4.4. Sedatives
4.4.5. Others
4.5. Market Size (US$ Mn) Forecast By Drug Type, 2017–2027
4.5.1.Psychostimulants
4.5.2. Narcotic
4.5.3. Hallucinogens
4.5.4. Sedatives
4.5.5.Others
4.6. Historical Market Size (US$ Mn) Analysis By Technique Type, 2012–2016
4.6.1.Immunoassay
4.6.2. Chromatography
4.6.3. Rapid Testing
4.7. Market Size (US$ Mn) Forecast By Technique Type, 2017–2027
4.7.1.Immunoassay
4.7.2. Chromatography
4.7.3. Rapid Testing
4.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016
4.8.1.Hospitals
4.8.2. Diagnostics Laboratories
4.8.3. Forensic Laboratories
4.8.4. Others
4.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
4.9.1.Hospitals
4.9.2. Diagnostics Laboratories
4.9.3. Forensic Laboratories
4.9.4. Others
4.10.Drivers and Restraints: Impact Analysis
4.11.Market Attractiveness Analysis
4.11.1. By Country
4.11.2. By Drug Type
4.11.3. By Technique Type
4.11.4. By End User
4.12.Key Representative Market Participants
4.13.Market Presence (Intensity Map)
5. Latin America Drugs of Abuse Testing Market Analysis 2012–2016 and Forecast 2017–2027
5.1. Introduction
5.2. Historical Market Size (US$ Mn) and Volume Analysis By Country, 2012–2016
5.2.1. Brazil
5.2.2. Mexico
5.2.3. Rest of Latin America
5.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017–2027
5.3.1. Brazil
5.3.2. Mexico
5.3.3. Rest of Latin America
5.4. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
5.4.1.Psychostimulants
5.4.2. Narcotic
5.4.3. Hallucinogens
5.4.4. Sedatives
5.4.5. Others
5.5. Market Size (US$ Mn) Forecast By Drug Type, 2017–2027
5.5.1.Psychostimulants
5.5.2. Narcotic
5.5.3. Hallucinogens
5.5.4. Sedatives
5.5.5.Others
5.6. Historical Market Size (US$ Mn) Analysis By Technique Type, 2012–2016
5.6.1.Immunoassay
5.6.2. Chromatography
5.6.3. Rapid Testing
5.7. Market Size (US$ Mn) Forecast By Technique Type, 2017–2027
5.7.1.Immunoassay
5.7.2. Chromatography
5.7.3. Rapid Testing
5.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016
5.8.1.Hospitals
5.8.2. Diagnostics Laboratories
5.8.3. Forensic Laboratories
5.8.4. Others
5.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
5.9.1.Hospitals
5.9.2. Diagnostics Laboratories
5.9.3. Forensic Laboratories
5.9.4. Others
5.10.Drivers and Restraints: Impact Analysis
5.11.Market Attractiveness Analysis
5.11.1. By Country
5.11.2. By Drug Type
5.11.3. By Technique Type
5.11.4. By End User
5.12.Key Representative Market Participants
5.13.Market Presence (Intensity Map)
6. Western Europe Drugs of Abuse Testing Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Introduction
6.2. Historical Market Size (US$ Mn) and Volume Analysis By Country, 2012–2016
6.2.1. U.K.
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Nordic Countries
6.2.7. Rest of Western Europe
6.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017–2027
6.3.1. U.K.
6.3.2. France
6.3.3. Germany
6.3.4. Italy
6.3.5. Spain
6.3.6. Nordic Countries
6.3.7. Rest of Western Europe
6.4. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
6.4.1.Psychostimulants
6.4.2. Narcotic
6.4.3. Hallucinogens
6.4.4. Sedatives
6.4.5. Others
6.5. Market Size (US$ Mn) Forecast By Drug Type, 2017–2027
6.5.1.Psychostimulants
6.5.2. Narcotic
6.5.3. Hallucinogens
6.5.4. Sedatives
6.5.5.Others
6.6. Historical Market Size (US$ Mn) Analysis By Technique Type, 2012–2016
6.6.1.Immunoassay
6.6.2. Chromatography
6.6.3. Rapid Testing
6.7. Market Size (US$ Mn) Forecast By Technique Type, 2017–2027
6.7.1.Immunoassay
6.7.2. Chromatography
6.7.3. Rapid Testing
6.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016
6.8.1.Hospitals
6.8.2. Diagnostics Laboratories
6.8.3. Forensic Laboratories
6.8.4. Others
6.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
6.9.1.Hospitals
6.9.2. Diagnostics Laboratories
6.9.3. Forensic Laboratories
6.9.4. Others
6.10.Drivers and Restraints: Impact Analysis
6.11.Market Attractiveness Analysis
6.11.1. By Country
6.11.2. By Drug Type
6.11.3. By Technique Type
6.11.4. By End User
6.12.Key Representative Market Participants
6.13.Market Presence (Intensity Map)
7. Eastern Europe Drugs of Abuse Testing Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Introduction
7.2. Historical Market Size (US$ Mn) and Volume Analysis By Country, 2012–2016
7.2.1. Russia
7.2.2. Poland
7.2.3. Rest of Eastern Europe
7.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017–2027
7.3.1. Russia
7.3.2. Poland
7.3.3. Rest of Eastern Europe
7.4. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
7.4.1.Psychostimulants
7.4.2. Narcotic
7.4.3. Hallucinogens
7.4.4. Sedatives
7.4.5. Others
7.5. Market Size (US$ Mn) Forecast By Drug Type, 2017–2027
7.5.1.Psychostimulants
7.5.2. Narcotic
7.5.3. Hallucinogens
7.5.4. Sedatives
7.5.5.Others
7.6. Historical Market Size (US$ Mn) Analysis By Technique Type, 2012–2016
7.6.1.Immunoassay
7.6.2. Chromatography
7.6.3. Rapid Testing
7.7. Market Size (US$ Mn) Forecast By Technique Type, 2017–2027
7.7.1.Immunoassay
7.7.2. Chromatography
7.7.3. Rapid Testing
7.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016
7.8.1.Hospitals
7.8.2. Diagnostics Laboratories
7.8.3. Forensic Laboratories
7.8.4. Others
7.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
7.9.1.Hospitals
7.9.2. Diagnostics Laboratories
7.9.3. Forensic Laboratories
7.9.4. Others
7.10.Drivers and Restraints: Impact Analysis
7.11.Market Attractiveness Analysis
7.11.1. By Country
7.11.2. By Drug Type
7.11.3. By Technique Type
7.11.4. By End User
7.12.Key Representative Market Participants
7.13.Market Presence (Intensity Map)
8. Asia Pacific excluding Japan Drugs of Abuse Testing Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
8.2.1. China
8.2.2. India
8.2.3. Australia and New Zealand
8.2.4. ASEAN
8.2.5. Rest of Asia Pacific
8.3. Market Size (US$ Mn) Forecast By Country, 2017–2027
8.3.1. China
8.3.2. India
8.3.3. Australia and New Zealand
8.3.4. ASEAN
8.3.5. Rest of Asia Pacific
8.4. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
8.4.1.Psychostimulants
8.4.2. Narcotic
8.4.3. Hallucinogens
8.4.4. Sedatives
8.4.5. Others
8.5. Market Size (US$ Mn) Forecast By Drug Type, 2017–2027
8.5.1.Psychostimulants
8.5.2. Narcotic
8.5.3. Hallucinogens
8.5.4. Sedatives
8.5.5.Others
8.6. Historical Market Size (US$ Mn) Analysis By Technique Type, 2012–2016
8.6.1.Immunoassay
8.6.2. Chromatography
8.6.3. Rapid Testing
8.7. Market Size (US$ Mn) Forecast By Technique Type, 2017–2027
8.7.1.Immunoassay
8.7.2. Chromatography
8.7.3. Rapid Testing
8.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016
8.8.1.Hospitals
8.8.2. Diagnostics Laboratories
8.8.3. Forensic Laboratories
8.8.4. Others
8.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
8.9.1.Hospitals
8.9.2. Diagnostics Laboratories
8.9.3. Forensic Laboratories
8.9.4. Others
8.10.Drivers and Restraints: Impact Analysis
8.11.Market Attractiveness Analysis
8.11.1. By Country
8.11.2. By Drug Type
8.11.3. By Technique Type
8.11.4. By End User
8.12.Key Representative Market Participants
8.13.Market Presence (Intensity Map)
9. Japan Drugs of Abuse Testing Market Analysis 2012–2016 and Forecast 2017–2027
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
9.2.1.Psychostimulants
9.2.2. Narcotic
9.2.3. Hallucinogens
9.2.4. Sedatives
9.2.5. Others
9.3. Market Size (US$ Mn) Forecast By Drug Type, 2017–2027
9.3.1.Psychostimulants
9.3.2. Narcotic
9.3.3. Hallucinogens
9.3.4. Sedatives
9.3.5.Others
9.4. Historical Market Size (US$ Mn) Analysis By Technique Type, 2012–2016
9.4.1.Immunoassay
9.4.2. Chromatography
9.4.3. Rapid Testing
9.5. Market Size (US$ Mn) Forecast By Technique Type, 2017–2027
9.5.1.Immunoassay
9.5.2. Chromatography
9.5.3. Rapid Testing
9.6. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016
9.6.1.Hospitals
9.6.2. Diagnostics Laboratories
9.6.3. Forensic Laboratories
9.6.4. Others
9.7. Market Size (US$ Mn) Forecast By End User, 2017–2027
9.7.1.Hospitals
9.7.2. Diagnostics Laboratories
9.7.3. Forensic Laboratories
9.7.4. Others
9.8. Drivers and Restraints: Impact Analysis
9.9. Market Attractiveness Analysis
9.9.1.By Drug Type
9.9.2.By Technique Type
9.9.3.By End User
9.10.Key Representative Market Participants
9.11.Market Presence (Intensity Map)
10. Middle East & Africa Drugs of Abuse Testing Market Analysis 2012–2016 and Forecast 2017–2027
10.1.Introduction
10.2.Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
10.2.1. South Africa
10.2.2. GCC Countries
10.2.3. Rest of MEA
10.3.Market Size (US$ Mn) Forecast By Country, 2017–2027
10.3.1. South Africa
10.3.2. GCC Countries
10.3.3. Rest of MEA
10.4.Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
10.4.1. Psychostimulants
10.4.2. Narcotic
10.4.3. Hallucinogens
10.4.4. Sedatives
10.4.5. Others
10.5.Market Size (US$ Mn) Forecast By Drug Type, 2017–2027
10.5.1. Psychostimulants
10.5.2. Narcotic
10.5.3. Hallucinogens
10.5.4. Sedatives
10.5.5. Others
10.6.Historical Market Size (US$ Mn) Analysis By Technique Type, 2012–2016
10.6.1. Immunoassay
10.6.2. Chromatography
10.6.3. Rapid Testing
10.7.Market Size (US$ Mn) Forecast By Technique Type, 2017–2027
10.7.1. Immunoassay
10.7.2. Chromatography
10.7.3. Rapid Testing
10.8.Historical Market Size (US$ Mn) Analysis By End User, 2012–2016
10.8.1. Hospitals
10.8.2. Diagnostics Laboratories
10.8.3. Forensic Laboratories
10.8.4. Others
10.9.Market Size (US$ Mn) Forecast By End User, 2017–2027
10.9.1. Hospitals
10.9.2. Diagnostics Laboratories
10.9.3. Forensic Laboratories
10.9.4. Others
10.10. Drivers and Restraints: Impact Analysis
10.11. Market Attractiveness Analysis
10.11.1. By Country
10.11.2. By Drug Type
10.11.3. By Technique Type
10.11.4. By End User
10.12. Key Representative Market Participants
10.13. Market Presence (Intensity Map)
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
13. Competition Landscape
13.1.Market Structure
13.2.Market Share Analysis
13.3.Competition Dashboard
13.4.Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
13.4.1. Quest Diagnostics
13.4.2. F. Hoffmann La-Roche Ltd
13.4.3. Siemens Healthineers (Siemens AG)
13.4.4. Thermo Fisher Scientific, Inc.
13.4.5. Alere, Inc. (Sub. Abbott Laboratories)
13.4.6. Shimadzu Corporation
13.4.7. Laboratory Corporation of America Holdings
13.4.8. Drägerwerk AG & Co. KGaA
13.4.9. Express Diagnostics International Inc.
14. Global Drugs of Abuse Testing Market Analysis 2012–2016 and Forecast 2017–2027, By Region
14.1.Introduction/Key Findings
14.2.Historical Market Size (US$ Mn) Analysis By Region, 2012–2016
14.2.1. North America
14.2.2. Latin America
14.2.3. Western Europe
14.2.4. Eastern Europe
14.2.5. Asia Pacific excluding Japan
14.2.6. Japan
14.2.7. Middle East & Africa
14.3.Market Size (US$ Mn) Forecast By Region, 2017–2027
14.3.1. North America
14.3.2. Latin America
14.3.3. Western Europe
14.3.4. Eastern Europe
14.3.5. Asia Pacific excluding Japan
14.3.6. Japan
14.3.7. Middle East & Africa
14.4.Market Attractiveness Analysis By Region
15. Global Drugs of Abuse Testing Market Analysis 2012–2016 and Forecast 2017–2027, By Drug Type
15.1.Introduction/Key Findings
15.2.Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
15.2.1. Psychostimulants
15.2.2. Narcotic
15.2.3. Hallucinogens
15.2.4. Sedatives
15.2.5. Others
15.3.Market Size (US$ Mn) Forecast By Drug Type, 2017–2027
15.3.1. Psychostimulants
15.3.2. Narcotic
15.3.3. Hallucinogens
15.3.4. Sedatives
15.3.5. Others
15.4.Market Attractiveness Analysis By Drug Type
16. Global Drugs of Abuse Testing Market Analysis 2012–2016 and Forecast 2017–2027, By Technique Type
16.1.Introduction/Key Findings
16.2.Historical Market Size (US$ Mn) Analysis By Technique Type, 2012–2016
16.2.1. Immunoassay
16.2.2. Chromatography
16.2.3. Rapid Testing
16.3.Market Size (US$ Mn) Forecast By Technique Type, 2017–2027
16.3.1. Immunoassay
16.3.2. Chromatography
16.3.3. Rapid Testing
16.4.Market Attractiveness Analysis By Technique Type
17. Global Drugs of Abuse Testing Market Analysis 2012–2016 and Forecast 2017–2027, By End User
17.1.Introduction/Key Findings
17.1.Historical Market Size (US$ Mn) Analysis By End User, 2012–2016
17.1.1. Hospitals
17.1.2. Diagnostics Laboratories
17.1.3. Forensic Laboratories
17.1.4. Others
17.2.Market Size (US$ Mn) Forecast By End User, 2017–2027
17.2.1. Hospitals
17.2.2. Diagnostics Laboratories
17.2.3. Forensic Laboratories
17.2.4. Others
17.3.Market Attractiveness Analysis By End User
18. Global Drugs of Abuse Testing Market Analysis 2012–2016 and Forecast 2017–2027
18.1.Market Size and Y-o-Y Growth
18.2.Absolute $ Opportunity
18.3.Value Chain
19. Research Methodology
Drug Of Abuse Testing Market Reports - List of Tables
Table 01 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Country
Table 02 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Drug Type
Table 03 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Technique Type
Table 04 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By End User
Table 05 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Country
Table 06 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Drug Type
Table 07 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Technique Type
Table 08 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By End User
Table 09 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Country
Table 10 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Drug Type
Table 11 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Technique Type
Table 12 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By End User
Table 13 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Country
Table 14 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Drug Type
Table 15 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Technique Type
Table 16 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By End User
Table 17 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Country
Table 18 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Drug Type
Table 19 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Technique Type
Table 20 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By End User
Table 21 : Japan Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Drug Type
Table 22 : Japan Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Technique Type
Table 23 : Japan Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By End User
Table 24 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Country
Table 25 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Drug Type
Table 26 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By Technique Type
Table 27 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis-2012–2016 and Opportunity Assessment 2017–2027, By End User
Table 28 : Global Drugs of Abuse Testing Market Size (US$ Mn) Forecast by Region, 2012–2027
Table 29 : Global Drugs of Abuse Testing Market Size (US$ Mn) Forecast By Drug Type, 2012–2027
Table 30 : Global Drugs of Abuse Testing Market Size (US$ Mn) Forecast By Technique Type, 2012–2027
Table 31 : Global Drugs of Abuse Testing Market Size (US$ Mn) Forecast By End User, 2012–2027
Drug Of Abuse Testing Market Reports - List of Figures
Figure 01 : North America Drugs of Abuse Testing Market Value Share By Drug Type (2017)
Figure 02 : North America Drugs of Abuse Testing Market Value Share By Technique Type (2017)
Figure 03 : North America Drugs of Abuse Testing Market Value Share By End User (2017)
Figure 04 : North America Drugs of Abuse Testing Market Value Share By Country (2017)
Figure 05 : North America Drugs of Abuse Testing Market Forecast 2017 and 2027
Figure 06 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 07 : North America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 08 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Psychostimulants
Figure 09 : North America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Psychostimulants
Figure 10 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Narcotic
Figure 11 : North America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Narcotic
Figure 12 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Hallucinogens
Figure 13 : North America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Hallucinogens
Figure 14 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Sedatives
Figure 15 : North America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Sedatives
Figure 16 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Others
Figure 17 : North America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Others
Figure 18 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Immunoassay
Figure 19 : North America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Immunoassay
Figure 20 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Chromatography
Figure 21 : North America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Chromatography
Figure 22 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Rapid Testing
Figure 23 : North America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Rapid Testing
Figure 24 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Hospitals
Figure 25 : North America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Hospitals
Figure 26 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Diagnostics Laboratories
Figure 27 : North America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Diagnostics Laboratories
Figure 28 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Forensic Laboratories
Figure 29 : North America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Forensic Laboratories
Figure 30 : North America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Others
Figure 31 : North America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others
Figure 32 : North America Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, By Drug Type
Figure 33 : North America Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, By Technique Type
Figure 34 : North America Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, by End User
Figure 35 : North America Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, by Country
Figure 36 : Latin America Drugs of Abuse Testing Market Value Share By Drug Type (2017)
Figure 37 : Latin America Drugs of Abuse Testing Market Value Share By Technique Type (2017)
Figure 38 : Latin America Drugs of Abuse Testing Market Value Share By End User (2017)
Figure 39 : Latin America Drugs of Abuse Testing Market Value Share By Country (2017)
Figure 40 : Latin America Drugs of Abuse Testing Market Forecast 2017 and 2027
Figure 41 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 42 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 43 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Psychostimulants
Figure 44 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Psychostimulants
Figure 45 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Narcotic
Figure 46 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Narcotic
Figure 47 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Hallucinogens
Figure 48 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Hallucinogens
Figure 49 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Sedatives
Figure 50 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Sedatives
Figure 51 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Others
Figure 52 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Others
Figure 53 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Immunoassay
Figure 54 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Immunoassay
Figure 55 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Chromatography
Figure 56 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Chromatography
Figure 57 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Rapid Testing
Figure 58 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Rapid Testing
Figure 59 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Hospitals
Figure 60 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Hospitals
Figure 61 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Diagnostics Laboratories
Figure 62 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Diagnostics Laboratories
Figure 63 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Forensic Laboratories
Figure 64 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Forensic Laboratories
Figure 65 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Others
Figure 66 : Latin America Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others
Figure 67 : Latin America Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, By Drug Type
Figure 68 : Latin America Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, By Technique Type
Figure 69 : Latin America Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, by End User
Figure 70 : Latin America Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, by Country
Figure 71 : Western Europe Drugs of Abuse Testing Market Value Share By Drug Type (2017)
Figure 72 : Western Europe Drugs of Abuse Testing Market Value Share By Technique Type (2017)
Figure 73 : Western Europe Drugs of Abuse Testing Market Value Share By End User (2017)
Figure 74 : Western Europe Drugs of Abuse Testing Market Value Share By Country (2017)
Figure 75 : Western Europe Drugs of Abuse Testing Market Forecast 2017 and 2027
Figure 76 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 77 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 78 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Psychostimulants
Figure 79 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Psychostimulants
Figure 80 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Narcotic
Figure 81 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Narcotic
Figure 82 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Hallucinogens
Figure 83 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Hallucinogens
Figure 84 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Sedatives
Figure 85 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Sedatives
Figure 86 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Others
Figure 87 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Others
Figure 88 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Immunoassay
Figure 89 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Immunoassay
Figure 90 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Chromatography
Figure 91 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Chromatography
Figure 92 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Rapid Testing
Figure 93 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Rapid Testing
Figure 94 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Hospitals
Figure 95 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Hospitals
Figure 96 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Diagnostics Laboratories
Figure 97 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Diagnostics Laboratories
Figure 98 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Forensic Laboratories
Figure 99 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Forensic Laboratories
Figure 100 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Others
Figure 101 : Western Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others
Figure 102 : Western Europe Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, By Drug Type
Figure 103 : Western Europe Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, By Technique Type
Figure 104 : Western Europe Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, by End User
Figure 105 : Western Europe Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, by Country
Figure 106 : Eastern Europe Drugs of Abuse Testing Market Value Share By Drug Type (2017)
Figure 107 : Eastern Europe Drugs of Abuse Testing Market Value Share By Technique Type (2017)
Figure 108 : Eastern Europe Drugs of Abuse Testing Market Value Share By End User (2017)
Figure 109 : Eastern Europe Drugs of Abuse Testing Market Value Share By Country (2017)
Figure 110 : Eastern Europe Drugs of Abuse Testing Market Forecast 2017 and 2027
Figure 111 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 112 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 113 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Psychostimulants
Figure 114 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Psychostimulants
Figure 115 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Narcotic
Figure 116 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Narcotic
Figure 117 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Hallucinogens
Figure 118 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Hallucinogens
Figure 119 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Sedatives
Figure 120 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Sedatives
Figure 121 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Others
Figure 122 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Others
Figure 123 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Immunoassay
Figure 124 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Immunoassay
Figure 125 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Chromatography
Figure 126 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Chromatography
Figure 127 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Rapid Testing
Figure 128 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Rapid Testing
Figure 129 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Hospitals
Figure 130 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Hospitals
Figure 131 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Diagnostics Laboratories
Figure 132 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Diagnostics Laboratories
Figure 133 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Forensic Laboratories
Figure 134 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Forensic Laboratories
Figure 135 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Others
Figure 136 : Eastern Europe Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others
Figure 137 : Eastern Europe Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, By Drug Type
Figure 138 : Eastern Europe Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, By Technique Type
Figure 139 : Eastern Europe Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, by End User
Figure 140 : Eastern Europe Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, by Country
Figure 141 : APEJ Drugs of Abuse Testing Market Value Share By Drug Type (2017)
Figure 142 : APEJ Drugs of Abuse Testing Market Value Share By Technique Type (2017)
Figure 143 : APEJ Drugs of Abuse Testing Market Value Share By End User (2017)
Figure 144 : APEJ Drugs of Abuse Testing Market Value Share By Country (2017)
Figure 145 : APEJ Drugs of Abuse Testing Market Forecast 2017 and 2027
Figure 146 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 147 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 148 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Psychostimulants
Figure 149 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Psychostimulants
Figure 150 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Narcotic
Figure 151 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Narcotic
Figure 152 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Hallucinogens
Figure 153 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Hallucinogens
Figure 154 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Sedatives
Figure 155 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Sedatives
Figure 156 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Others
Figure 157 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Others
Figure 158 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Immunoassay
Figure 159 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Immunoassay
Figure 160 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Chromatography
Figure 161 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Chromatography
Figure 162 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Rapid Testing
Figure 163 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Rapid Testing
Figure 164 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Hospitals
Figure 165 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Hospitals
Figure 166 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Diagnostics Laboratories
Figure 167 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Diagnostics Laboratories
Figure 168 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Forensic Laboratories
Figure 169 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Forensic Laboratories
Figure 170 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Others
Figure 171 : APEJ Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others
Figure 172 : APEJ Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, By Drug Type
Figure 173 : APEJ Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, By Technique Type
Figure 174 : APEJ Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, by End User
Figure 175 : APEJ Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, by Country
Figure 176 : Japan Drugs of Abuse Testing Market Value Share By Drug Type (2017)
Figure 177 : Japan Drugs of Abuse Testing Market Value Share By Technique Type (2017)
Figure 178 : Japan Drugs of Abuse Testing Market Value Share By End User (2017)
Figure 179 : Japan Drugs of Abuse Testing Market Forecast 2017 and 2027
Figure 180 : Japan Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 181 : Japan Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 182 : Japan Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Psychostimulants
Figure 183 : Japan Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Psychostimulants
Figure 184 : Japan Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Narcotic
Figure 185 : Japan Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Narcotic
Figure 186 : Japan Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Hallucinogens
Figure 187 : Japan Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Hallucinogens
Figure 188 : Japan Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Sedatives
Figure 189 : Japan Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Sedatives
Figure 190 : Japan Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Others
Figure 191 : Japan Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Others
Figure 192 : Japan Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Immunoassay
Figure 193 : Japan Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Immunoassay
Figure 194 : Japan Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Chromatography
Figure 195 : Japan Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Chromatography
Figure 196 : Japan Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Rapid Testing
Figure 197 : Japan Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Rapid Testing
Figure 198 : Japan Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Hospitals
Figure 199 : Japan Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Hospitals
Figure 200 : Japan Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Diagnostics Laboratories
Figure 201 : Japan Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Diagnostics Laboratories
Figure 202 : Japan Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Forensic Laboratories
Figure 203 : Japan Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Forensic Laboratories
Figure 204 : Japan Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Others
Figure 205 : Japan Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others
Figure 206 : Japan Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, By Drug Type
Figure 207 : Japan Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, By Technique Type
Figure 208 : Japan Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, by End User
Figure 209 : MEA Drugs of Abuse Testing Market Value Share By Drug Type (2017)
Figure 210 : MEA Drugs of Abuse Testing Market Value Share By Technique Type (2017)
Figure 211 : MEA Drugs of Abuse Testing Market Value Share By End User (2017)
Figure 212 : MEA Drugs of Abuse Testing Market Value Share By Country (2017)
Figure 213 : MEA Drugs of Abuse Testing Market Forecast 2017 and 2027
Figure 214 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 215 : MEA Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 216 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Psychostimulants
Figure 217 : MEA Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Psychostimulants
Figure 218 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Narcotic
Figure 219 : MEA Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Narcotic
Figure 220 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Hallucinogens
Figure 221 : MEA Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Hallucinogens
Figure 222 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Sedatives
Figure 223 : MEA Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Sedatives
Figure 224 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Others
Figure 225 : MEA Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Others
Figure 226 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Immunoassay
Figure 227 : MEA Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Immunoassay
Figure 228 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Chromatography
Figure 229 : MEA Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Chromatography
Figure 230 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Rapid Testing
Figure 231 : MEA Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Rapid Testing
Figure 232 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Hospitals
Figure 233 : MEA Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Hospitals
Figure 234 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Diagnostics Laboratories
Figure 235 : MEA Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Diagnostics Laboratories
Figure 236 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Forensic Laboratories
Figure 237 : MEA Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Forensic Laboratories
Figure 238 : MEA Drugs of Abuse Testing Market Size (US$ Mn) Analysis, 2012–2016, by Others
Figure 239 : MEA Drugs of Abuse Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others
Figure 240 : MEA Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, By Drug Type
Figure 241 : MEA Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, By Technique Type
Figure 242 : MEA Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, by End User
Figure 243 : MEA Drugs of Abuse Testing Market Attractiveness Analysis, 2017–2027, by Country
Figure 244 : Global Drugs of Abuse Testing Market Attractiveness Analysis by Region, 2017–2027
Figure 245 : Global Drugs of Abuse Testing Market Attractiveness Analysis By Drug Type, 2017–2027
Figure 246 : Global Drugs of Abuse Testing Market Attractiveness Analysis By Technique Type, 2017–2027
Figure 247 : Global Drugs of Abuse Testing Market Attractiveness Analysis By End User, 2017–2027
Figure 248 : Global Drugs of Abuse Testing Market Value Analysis and Forecast, 2016–2027 (US$ Mn)
Figure 249 : Global Drugs of Abuse Testing Market Absolute $ Opportunity (US$ Mn), 2012–2016
Figure 250 : Global Drugs of Abuse Testing Market Absolute $ Opportunity (US$ Mn), 2016–2027